GR
Gerresheimer AG
GRRMF · OTC
$32.20 +0.00% (+$0.00)
1M +3.40%
Market Cap 956.3M €
P/E Ratio -
Div. Yield -
ROE 23.57%
Bulios Fair Price
$17.87
44.5% downside
Current Price
$32.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GRRMF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
93 /100
Cheap P/S 0.41x
P/B 0.88x
EV/EBITDA 8.60x
Growth
64 /100
Stable Rev. growth 10.77%
Book val. growth 15.49%
EPS growth 6.00%
Profitability
8 /100
Weak Net margin 13.80%
Op. margin 9.02%
FCF margin 4.26%
Quality
6 /100
Poor ROE 23.57%
ROA 7.13%
Asset turnover 0.52x
Debt
8 /100
High Current ratio 0.81x
Int. coverage -0.86x
Net debt/EBITDA 5.94x
Stability
87 /100
Stable Rev. volatility 9.60%
EPS volatility 13.16%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRRMF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Uwe Ferdinand Röhrhoff
Employees
13,528
Headquarters
Düsseldorf
Upcoming events
16 SEP
Earnings
Upcoming earnings report